Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Closed testing using surrogate hypotheses with restricted alternatives.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • المؤلفون: Lachin JM;Lachin JM; Bebu I; Bebu I; Larsen MD; Larsen MD; Younes N; Younes N
  • المصدر:
    PloS one [PLoS One] 2019 Jul 12; Vol. 14 (7), pp. e0219520. Date of Electronic Publication: 2019 Jul 12 (Print Publication: 2019).
  • نوع النشر :
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • اللغة:
    English
  • معلومة اضافية
    • المصدر:
      Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: San Francisco, CA : Public Library of Science
    • الموضوع:
    • نبذة مختصرة :
      Introduction: The closed testing principle provides strong control of the type I error probabilities of tests of a set of hypotheses that are closed under intersection such that a given hypothesis H can only be tested and rejected at level α if all intersection hypotheses containing that hypothesis are also tested and rejected at level α. For the higher order hypotheses, multivariate tests (> 1df) are generally employed. However, such tests are directed to an omnibus alternative hypothesis of a difference in any direction for any component that may be less meaningful than a test directed against a restricted alternative hypothesis of interest.
      Methods: Herein we describe applications of this principle using an α-level test of a surrogate hypothesis [Formula: see text] such that the type I error probability is preserved if [Formula: see text] such that rejection of [Formula: see text] implies rejection of H. Applications include the analysis of multiple event times in a Wei-Lachin test against a one-directional alternative, a test of the treatment group difference in the means of K repeated measures using a 1 df test of the difference in the longitudinal LSMEANS, and analyses within subgroups when a test of treatment by subgroup interaction is significant. In such cases the successive higher order surrogate tests can be aimed at detecting parameter values that fall within a more desirable restricted subspace of the global alternative hypothesis parameter space.
      Conclusion: Closed testing using α-level tests of surrogate hypotheses will protect the type I error probability and detect specific alternatives of interest, as opposed to the global alternative hypothesis of any difference in any direction.
      Competing Interests: The authors have declared that no competing interests exist.
    • References:
      Clin Trials. 2015 Dec;12(6):627-33. (PMID: 26336199)
      Stat Biopharm Res. 2015;7(2):126-147. (PMID: 26366251)
      Stat Med. 2018 Nov 30;37(27):3918-3930. (PMID: 29956365)
      N Engl J Med. 2004 Nov 11;351(20):2058-68. (PMID: 15531767)
      Biometrics. 1991 Jun;47(2):511-21. (PMID: 1912258)
      Biometrics. 1984 Dec;40(4):1079-87. (PMID: 6534410)
      PLoS One. 2014 Oct 17;9(10):e108784. (PMID: 25329662)
      N Engl J Med. 2007 Nov 22;357(21):2189-94. (PMID: 18032770)
    • Grant Information:
      U01 DK098246 United States DK NIDDK NIH HHS
    • الموضوع:
      Date Created: 20190713 Date Completed: 20200309 Latest Revision: 20200309
    • الموضوع:
      20231215
    • الرقم المعرف:
      PMC6625735
    • الرقم المعرف:
      10.1371/journal.pone.0219520
    • الرقم المعرف:
      31299051